(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DXME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DXME

ST13

US500000079167565

Class

5, 10

Filing

79167565

Registration

4948575

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

05/04/2025

Trademark type

Combined

Nice classes

5, 10

Filing date

01/30/2015

Registration date

05/03/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/15/2022

Last transaction

05/04/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

98

Owner location

KR

Examiner

MALASHEVICH, JASON

Law office

M50

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the literal element "DXME" in bold font, with the letters "D" and "M" in the uppercase, and all other letters in the lowercase.

Holders and representatives

Holders

E&S Healthcare Co., Ltd.

Representatives

Patricia A Wilczynski Brozek POKALSKY WILCZYNSKI BROZEK LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical reagents for medical or veterinary purposes; reagent paper for medical or veterinary purposes; diagnostic medical reagents for immunoassayfor detecting or measuring specific proteins or other substances through their properties as antigens or antibodies; clinical diagnostic reagents; analytic reagents for medical use; diagnostic reagents for medical use; measurement reagents for medical use; clinical diagnostic preparations; diagnostic reagents for medical usediagnostic reagents for blood analysis

Class 10

Diagnostic apparatus for medical purposesfor the detection of cancer; apparatus for blood analysis; diagnostic apparatus for detecting cancer; diagnostic apparatus for detecting breast cancer; medical apparatus and instruments other than for dental purposesfor the detection of cancer

Publications

History of USPTO decisions and trademark events.

38 publications found

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

05/03/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/07/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

11/14/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/11/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

09/16/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

08/16/2023

INPC

INVALIDATION PROCESSED

08/15/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

07/15/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

11/15/2022

71AG

REGISTERED-SEC.71 ACCEPTED

11/15/2022

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

11/14/2022

PUM1

OFFICE ACTION ISSUED POU1

05/12/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/09/2022

ES71

TEAS SECTION 71 RECEIVED

04/27/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/26/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/09/2016

FIMP

FINAL DISPOSITION PROCESSED

08/09/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/03/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/28/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

05/03/2016

PUBO

PUBLISHED FOR OPPOSITION

02/16/2016

GPNX

NOTIFICATION PROCESSED BY IB

02/13/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/27/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/27/2016

NPUB

NOTICE OF PUBLICATION

01/27/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/31/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/30/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/30/2015

RFNT

REFUSAL PROCESSED BY IB

07/18/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/30/2015

RFRR

REFUSAL PROCESSED BY MPU

06/30/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/30/2015

MAFR

APPLICATION FILING RECEIPT MAILED

06/30/2015

CNRT

NON-FINAL ACTION WRITTEN

06/29/2015

DOCK

ASSIGNED TO EXAMINER

06/26/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/26/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/25/2015

Continuous trademark protection

Get notified about every new filing that threatens DXME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.